← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mandalmed, Inc.
San Francisco, CA
$5,725,285
Total funding
12
Grants
Funding over time
peak $1.5M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,725,285 · 12
By mechanism
R44$2,975,919 · 2
R43$2,749,366 · 10
Investigators at Mandalmed, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction$1,061,083
R44 · FY2018 · AG
Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction$808,592
R44 · FY2017 · AG
Novel Ex Vivo Gene Therapy for Spinal Cord Injury$375,427
R44 · FY2004 · HD
Novel Ex Vivo Gene Therapy for Spinal Cord Injury$374,553
R44 · FY2003 · HD
Preclinical Testing of Galectin-3C for Multiple Myeloma$363,936
R43 · FY2008 · CA
Cell-based Gene Therapy for MPS IVA$306,872
R43 · FY2024 · AR
Protein inhibitor of galectin-3 to limit fibrosis after myocardial infarction$299,958
R43 · FY2013 · HL
Biologic Inhibitor of Galectin-3 for Liver Fibrosis$299,900
R43 · FY2018 · DK
Novel Treatment for Breast Cancer: Truncated Galectin-3$255,495
R43 · FY2002 · CA
Human Sertoli Cell Model for Study of Male Reproductive Function and Toxicity$255,200
R43 · FY2007 · HD
Model of the Human Testis for Reproductive Toxicology$250,000
R43 · FY2011 · ES
Novel Treatment for Breast Cancer: Truncated Galectin-3$236,893
R43 · FY2001 · CA
Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction$224,734
R44 · FY2016 · AG
Novel Ex Vivo Gene Therapy for Spinal Cord Injury$155,695
R43 · FY2002 · HD
CELLS FOR PROTECTION OF IMPLANTED B ISLETS$142,130
R43 · FY2000 · DK
NO-donor/SOD-mimetics for diabetic nephropathy$134,000
R43 · FY2005 · DK
Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction Supplement$131,530
R44 · FY2018 · AG
PLACENTAL CELLS FOR PROTECTION OF IMPLANTED B ISLETS$49,287
R43 · FY2000 · DK